Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...

Philip Morris International Inc. reported better-than expected profit, as sales of Zyn nicotine pouches rose more than 25% ...

Philip Morris (NYSE:PM) is set to report fourth quarter earnings on Thursday, and investors’ focus will be on the global tobacco giant’s smoke-free products (SFPs) business as health-conscious ...

Philip Morris International (NYSE:PM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” ...

Philip Morris is a leading dividend business with strong smoke-free product growth, including IQOS and ZYN. Read why PM stock ...

Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.

Managing Director Hannah Yun emphasized the importance of scientifically proven data in persuading the government about the ...

Overall, the quarter highlighted Philip Morris's strategic shift towards smoke-free products, supporting a strong financial performance despite lingering reliance on traditional tobacco products.

Philip Morris International Inc. (NYSE:PM – Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday following a better than expected earnings announcement. The stock ...

Philip Morris International Inc (PM) reports robust growth in smoke-free products and record operating cash flow, despite ...

Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine ... it was up 9% to $142.67, hitting a new high, according to Dow Jones Market Data.